NIJ Controlled Substances Case Processing Study
Total Page:16
File Type:pdf, Size:1020Kb
The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: NIJ Controlled Substances Case Processing Study Author: Kevin J. Strom, Hope Smiley McDonald, Peter R. Stout, Jeri D. Ropero-Miller, and Jamia Bachrach Document No.: 233830 Date Received: March 2011 Award Number: 2007F_07164 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. August 2010 NIJ Controlled Substances Case Processing Study Final Report Prepared for Brett Chapman National Institute of Justice 810 7th Street, NW Washington, DC 20531 Phone: 202-514-2187 Fax: 202-616-0275 [email protected] Prepared by Kevin J. Strom Hope Smiley McDonald Peter R. Stout Jeri D. Ropero-Miller Jamia Bachrach RTI International 3040 Cornwallis Road Research Triangle Park, NC 27709 RTI Project Number 0209266.002 This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. RTI Project Number 0209266.002 NIJ Controlled Substances Case Processing Study Final Report August 2010 Prepared for Brett Chapman National Institute of Justice 810 7th Street, NW Washington, DC 20531 Phone: 202-514-2187 Fax: 202-616-0275 [email protected] Prepared by Kevin J. Strom Hope Smiley McDonald Peter Stout Jeri Ropero-Miller Jamia Bachrach RTI International 3040 Cornwallis Road Research Triangle Park, NC 27709 _________________________________ RTI International is a trade name of Research Triangle Institute. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Contents Section Page Study Abstract SA-1 Executive Summary ES-1 1. Introduction 1-1 1.1 Study Background .................................................................................. 1-1 1.2 Study Objectives .................................................................................... 1-3 2. Background and Overview 2-1 2.1 Impact of Drug Evidence on Forensic Backlogs ........................................... 2-1 2.2 Challenges of Drug Evidence .................................................................... 2-4 2.3 Roles of Law Enforcement, Prosecutors, and Laboratories in Processing Drug Cases ........................................................................................... 2-5 2.4 Legal Factors in Drug Cases ..................................................................... 2-7 2.4.1 Background: The Sixth Amendment and the Confrontation Clause ....... 2-7 2.4.2 Melendez-Diaz v. Massachusetts ..................................................... 2-8 2.4.3 Briscoe v. Virginia ........................................................................ 2-9 3. Research Methods 3-1 3.1 Development of Interview Guides ............................................................. 3-1 3.2 Site Selection Process ............................................................................. 3-2 3.3 Site Visits and Administering the Interviews ............................................... 3-2 3.4 Analyzing and Reporting the Findings ........................................................ 3-3 4. Results 4-1 4.1 Law Enforcement: Investigating and Processing Drug Evidence ..................... 4-1 4.1.1 Collection and Use of Drug Evidence ............................................... 4-1 4.1.2 Presumptive Field Tests .................................................................. 4-2 4.1.3 Procedures for Processing and Submitting Evidence to Crime Laboratories ................................................................................ 4-4 4.1.4 Evidence Tracking Systems ............................................................ 4-5 4.1.5 Evidence Destruction and Storage ................................................... 4-5 4.1.6 Law Enforcement Communication and Coordination ........................... 4-6 iii This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. 4.2 Forensic Laboratories: Procedures for Receiving and Analyzing Drug Evidence ............................................................................................... 4-7 4.2.1 Case Acceptance Policies ............................................................... 4-7 4.2.2 Receiving, Tracking, Analyzing, and Reporting Evidence .................... 4-12 4.2.3 Testifying in Court ....................................................................... 4-13 4.2.4 Managing/Eliminating Backlogs and Finding Case Processing Efficiencies ................................................................................. 4-16 4.2.5 Interagency Communication and Coordination ................................. 4-19 4.3 Prosecution: Use of Forensic Evidence in Charging by Prosecutors. ............... 4-19 4.3.1 Case Prioritization and Charging Decisions ...................................... 4-20 4.3.2 Field Tests and Plea Agreements.................................................... 4-20 4.3.3 Use of Drug Analysis Results in Trial .............................................. 4-20 4.3.4 Prosecutor Communication and Coordination ................................... 4-21 5. Conclusion 5-1 5.1 Study Implications and Recommendations ................................................. 5-1 5.1.1 Recommendation 1: Define, Implement, and Enforce Laboratory Submission Policies ....................................................................... 5-1 5.1.2 Recommendation 2: Promote Regular Two-Way Communication ......... 5-2 5.1.3 Recommendation 3: Implement Case Tracking or Case Reporting System to Improve Cross-Agency Information Sharing ...................... 5-2 5.1.4 Recommendation 4: Improve Training across All Three Criminal Justice Stakeholders ..................................................................... 5-2 5.1.5 Recommendation 5: Improve and Increase Judicial Resources ............ 5-3 5.1.6 Recommendation 6: Implement Solutions that Allow Laboratories to Catch-Up on Their Backlogs ........................................................ 5-4 5.1.7 Recommendation 7: Dedicate Federal Funding Sources to Non-DNA Laboratory Functions .................................................................... 5-5 5.1.8 Recommendation 8: Improve Testimony Efficiency ............................ 5-5 5.1.9 Recommendation 9. Provide Better Guidance to Law Enforcement Agencies on Drug Evidence Destruction ........................................... 5-6 5.2 Study Limitations ................................................................................... 5-6 5.3 Conclusions ........................................................................................... 5-6 6. References 6-1 Appendixes A Overview of Legal Procedures .................................................................. A-1 B Stakeholder Interview Guide: Forensic Laboratory Staff .............................. B-1 C Stakeholder Interview Guide: Law Enforcement .......................................... C-1 D Stakeholder Interview Guide: Prosecutors ................................................. D-1 iv This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Figures Number Page 1-1 Summary of Data Collection Topics ...............................................................